Centrosomes are involved in mitotic spindle organization and an increasing number of other fundamental cellular processes. Defects in centrosomes contribute to spindle defects, chromosome missegregation and aneuploidy. Recent work initially from our labraotory and one other showed that centrosome defects are a characteristic feature of human tumors. The long-term goal of our laboratory is to gain insight into the function of centrosomes and centrosome proteins in fundamental cellular processes and human cancer, toward this goal, we recently discovered that the centrosome protein pericentrin interacts with proteins of the nucleosome remodeling and deacetylase (NuRD) complex. Our preliminary results show that NuRD complex components are at the centrosome and that alteration of their levels affects centrosome integrity, spindle organization and genetic stability. We unexpectedly found that pericentrin localizes to the nucleus and that functional abrogation of pericentrin has dramatic effects on nuclear structure. We have also shown that pericentrin induces the formation of multipolar spindles when elevated in cells and mislocalizes dynein from spindles. Other work confirms that loss of dynein from mitotic spindles induces multipolarity and shows that re-establishing dynein binding to spindles results in clustering of spindle poles and restoration of spindle bipority. Based on these observations we propose three specific aims:
Aim 1. To determine the mechanism of centrosome disruption and spindle dysfunction in cells with abrogated NuRD components.
Aim 2. To determine the mechanism of nuclear disruption and functional changes in nuclei following abrogation of pericentrin function.
Aim 3. To restore spindle bipolarity in tumor cells that have multipolar spindles and elevated levels of pericentrin as was accomplished in tumor cells overexpressing another dynein-interacting protein, NuMA. If successful this work will increase our basic understanding of centrosomes and centrosome proteins. In addition, it will provide information on how cells develop genetic changes that accompany human tumorigenesis. This could prove useful in cancer diagnosis and prognosis, and provide new targets for designing cancer therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA082834-09
Application #
7760062
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
9
Fiscal Year
2009
Total Cost
$237,218
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
DUNS #
603847393
City
Worcester
State
MA
Country
United States
Zip Code
01655
Fritz, Andrew J; Ghule, Prachi N; Boyd, Joseph R et al. (2018) Intranuclear and higher-order chromatin organization of the major histone gene cluster in breast cancer. J Cell Physiol 233:1278-1290
Araya, Héctor F; Sepulveda, Hugo; Lizama, Carlos O et al. (2018) Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2. J Cell Biochem 119:8204-8219
Carver, Gary E; Locknar, Sarah A; Weaver, Donald L et al. (2018) Real-time detection of breast cancer at the cellular level. J Cell Physiol :
Tracy, Kirsten M; Tye, Coralee E; Ghule, Prachi N et al. (2018) Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer. Mol Cancer Res 16:587-598
Zaidi, Sayyed K; Fritz, Andrew J; Tracy, Kirsten M et al. (2018) Nuclear organization mediates cancer-compromised genetic and epigenetic control. Adv Biol Regul 69:1-10
Hong, Deli; Fritz, Andrew J; Finstad, Kristiaan H et al. (2018) Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor. Mol Cancer Res 16:1952-1964
Zaidi, Sayyed K; Nickerson, Jeffrey A; Imbalzano, Anthony N et al. (2018) Mitotic Gene Bookmarking: An Epigenetic Program to Maintain Normal and Cancer Phenotypes. Mol Cancer Res 16:1617-1624
Hong, Deli; Fritz, Andrew J; Zaidi, Sayyed K et al. (2018) Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity. J Cell Physiol 233:9136-9144
Farina, Nicholas H; Zingiryan, Areg; Vrolijk, Michael A et al. (2018) Nanoparticle-based targeted cancer strategies for non-invasive prostate cancer intervention. J Cell Physiol 233:6408-6417
Tracy, Kirsten M; Tye, Coralee E; Page, Natalie A et al. (2018) Selective expression of long non-coding RNAs in a breast cancer cell progression model. J Cell Physiol 233:1291-1299

Showing the most recent 10 out of 213 publications